ストックスクリーナーアプリを入手
29.71
0.87%
-0.26
前日終値:
$29.97
開ける：
$29.76
24時間の取引高:
4.15M
Relative Volume:
2.40
時価総額：
$4.81B
収益：
$1.51B
当期純損益:
$333.35M
株価収益率:
23.96
EPS:
1.24
ネットキャッシュフロー:
$315.22M
1週間 パフォーマンス:
-2.62%
1か月 パフォーマンス:
+6.45%
6か月 パフォーマンス:
+18.60%
1年 パフォーマンス:
+9.31%
1日の値動き範囲:
$29.53
$30.37
1週間の範囲:
$29.53
$31.18
52週間の値動き範囲:
$22.90
$32.88
Alkermes Plc Stock (ALKS) Company Profile
ALKS を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ALKS
Alkermes Plc
|
29.71 | 4.81B | 1.51B | 333.35M | 315.22M | 1.95 |
|
ZTS
Zoetis Inc
|
164.84 | 74.37B | 9.15B | 2.43B | 2.31B | 5.32 |
|
HLN
Haleon Plc Adr
|
9.69 | 43.81B | 14.26B | 1.55B | 0 | 0.3383 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.10 | 41.53B | 30.27B | 1.93B | 3.45B | 0.6044 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
22.09 | 25.03B | 16.77B | -959.00M | 1.37B | -0.85 |
|
VTRS
Viatris Inc
|
12.52 | 14.94B | 15.05B | -883.30M | 1.89B | -0.74 |
Alkermes Plc Stock (ALKS) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-11-05 | アップグレード | Stifel | Hold → Buy |
| 2024-06-17 | 開始されました | TD Cowen | Buy |
| 2024-03-19 | 開始されました | Robert W. Baird | Outperform |
| 2024-02-20 | ダウングレード | UBS | Neutral → Sell |
| 2023-11-20 | 再開されました | JP Morgan | Neutral |
| 2023-10-24 | アップグレード | Evercore ISI | In-line → Outperform |
| 2023-10-17 | 開始されました | UBS | Neutral |
| 2022-11-03 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2022-10-14 | アップグレード | BofA Securities | Underperform → Neutral |
| 2022-08-16 | 開始されました | Piper Sandler | Neutral |
| 2022-04-22 | 再開されました | Goldman | Buy |
| 2022-04-20 | 開始されました | Goldman | Buy |
| 2022-01-27 | アップグレード | Cantor Fitzgerald | Hold → Overweight |
| 2021-12-01 | 開始されました | Citigroup | Neutral |
| 2021-10-07 | アップグレード | Jefferies | Hold → Buy |
| 2021-09-02 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2020-10-15 | アップグレード | Mizuho | Neutral → Buy |
| 2020-07-30 | ダウングレード | Goldman | Neutral → Sell |
| 2020-02-14 | ダウングレード | BofA/Merrill | Buy → Neutral |
| 2020-02-14 | 繰り返されました | H.C. Wainwright | Neutral |
| 2020-02-14 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2020-02-06 | 開始されました | Mizuho | Neutral |
| 2020-01-31 | アップグレード | Wolfe Research | Underperform → Peer Perform |
| 2019-09-05 | アップグレード | Morgan Stanley | Underweight → Equal-Weight |
| 2019-07-15 | アップグレード | Goldman | Sell → Neutral |
| 2019-05-31 | 開始されました | H.C. Wainwright | Neutral |
| 2019-05-01 | ダウングレード | Citigroup | Buy → Neutral |
| 2018-12-19 | ダウングレード | Goldman | Neutral → Sell |
| 2018-12-14 | 開始されました | Wolfe Research | Underperform |
| 2018-12-13 | ダウングレード | Credit Suisse | Outperform → Underperform |
| 2018-11-05 | 開始されました | Piper Jaffray | Neutral |
| 2018-08-07 | 開始されました | Stifel | Hold |
| 2018-06-21 | ダウングレード | Morgan Stanley | Equal-Weight → Underweight |
| 2018-06-06 | 開始されました | B. Riley FBR, Inc. | Buy |
| 2018-05-16 | アップグレード | Citigroup | Neutral → Buy |
| 2018-05-11 | 開始されました | BofA/Merrill | Buy |
すべてを表示
Alkermes Plc (ALKS) 最新ニュース
Expansion Therapeutics Names Elliot Ehrich, MD, Chief Medical Officer - Marketscreener.com
Alkermes pays off and terminates major credit agreement By Investing.com - Investing.com Canada
2025 will be a big year for Mural Oncology's drugs in development - The Business Journals
Alkermes pays off and terminates major credit agreement - Investing.com
Tidal Investments LLC Invests $1.10 Million in Alkermes plc (NASDAQ:ALKS) - MarketBeat
Alkermes Prepares for New Flexibility Post Credit Termination - TipRanks
Geode Capital Management LLC Sells 60,037 Shares of Alkermes plc (NASDAQ:ALKS) - MarketBeat
We Think Alkermes (NASDAQ:ALKS) Can Stay On Top Of Its Debt - Simply Wall St
Wilmington Savings Fund Society FSB Invests $582,000 in Alkermes plc (NASDAQ:ALKS) - MarketBeat
Barclays PLC Boosts Holdings in Alkermes plc (NASDAQ:ALKS) - MarketBeat
Alkermes To Take Part In The Fourth Annual Evercore ISI Healthconx Conference - Environmental Expert
Opioid Use Disorder Market: Share, Key Trends, Growth Drivers, - openPR
When (ALKS) Moves Investors should Listen - Stock Traders Daily
Fmr LLC Has $9.71 Million Stake in Alkermes plc (NASDAQ:ALKS) - MarketBeat
State Street Corp Lowers Stake in Alkermes plc (NASDAQ:ALKS) - MarketBeat
Alkermes plc (NASDAQ:ALKS) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
Alkermes' EVP Craig Hopkinson sells shares worth $1.96 million By Investing.com - Investing.com South Africa
Frazier Life Sciences Management L.P. Acquires New Stake in Alkermes plc (NASDAQ:ALKS) - MarketBeat
Alkermes director Cato Laurencin sells $85,708 in stock By Investing.com - Investing.com Canada
Alkermes' EVP Craig Hopkinson sells shares worth $1.96 million - Investing.com
Wellington Management Group LLP Sells 1,696,507 Shares of Alkermes plc (NASDAQ:ALKS) - MarketBeat
Alkermes plc (NASDAQ:ALKS) Stake Lifted by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - MarketBeat
Insider Sell: Craig Hopkinson Sells 9,221 Shares of Alkermes PLC (ALKS) - GuruFocus.com
Alkermes' chief medical officer sells $290,461 in stock By Investing.com - Investing.com Australia
Alkermes' chief medical officer sells $290,461 in stock - Investing.com India
Insider Sell: Craig Hopkinson Sells 14,349 Shares of Alkermes PL - GuruFocus.com
RTW Investments LP Sells 402,955 Shares of Alkermes plc (NASDAQ:ALKS) - MarketBeat
BNP Paribas Financial Markets Buys 63,939 Shares of Alkermes plc (NASDAQ:ALKS) - MarketBeat
Alkermes EVP and chief medical officer sells shares worth $441,550 By Investing.com - Investing.com Canada
Alkermes EVP and chief medical officer sells shares worth $441,550 - Investing.com
Alkermes PLC (ALKS) Shares Up 4.58% on Dec 4 - GuruFocus.com
Drug Addiction Treatment Market Future Business Opportunities - openPR
Citigroup Inc. Buys 65,536 Shares of Alkermes plc (NASDAQ:ALKS) - MarketBeat
Charles Schwab Investment Management Inc. Has $58.98 Million Stock Position in Alkermes plc (NASDAQ:ALKS) - MarketBeat
Public Sector Pension Investment Board Reduces Position in Alkermes plc (NASDAQ:ALKS) - MarketBeat
Fisher Asset Management LLC Acquires 18,147 Shares of Alkermes plc (NASDAQ:ALKS) - MarketBeat
Alkermes plc (NASDAQ:ALKS) Stock Position Reduced by Connor Clark & Lunn Investment Management Ltd. - MarketBeat
Insider Sell: Christian Nichols Sells Shares of Alkermes PLC - GuruFocus.com
Alkermes SVP Nichols sells $151,813 in stock By Investing.com - Investing.com Nigeria
Alkermes SVP Nichols sells $151,813 in stock - Investing.com India
Pathstone Holdings LLC Has $2 Million Stake in Alkermes plc (NASDAQ:ALKS) - MarketBeat
Natixis Advisors LLC Increases Position in Alkermes plc (NASDAQ:ALKS) - MarketBeat
Axsome Therapeutics eyes approval after Phase III narcolepsy win - Clinical Trials Arena
Loomis Sayles & Co. L P Purchases 1,478,422 Shares of Alkermes plc (NASDAQ:ALKS) - MarketBeat
Intech Investment Management LLC Buys New Shares in Alkermes plc (NASDAQ:ALKS) - MarketBeat
Alkermes to Participate in Upcoming Investor Conferences - StreetInsider.com
Alkermes: Products Sales, ALKS 2680 Can Still Drive Long-Term Growth - Seeking Alpha
Eagle Asset Management Inc. Trims Holdings in Alkermes plc (NASDAQ:ALKS) - MarketBeat
Victory Capital Management Inc. Grows Position in Alkermes plc (NASDAQ:ALKS) - MarketBeat
Alkermes Plc (ALKS) 財務データ
収益
当期純利益
現金流量
EPS
Alkermes Plc (ALKS) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Hopkinson Craig C. | EVP R&D, Chief Medical Officer |
Dec 09 '24 |
Sale |
32.07 |
61,151 |
1,961,406 |
47,576 |
| LAURENCIN CATO T | Director |
Dec 09 '24 |
Option Exercise |
22.52 |
2,691 |
60,601 |
25,704 |
| LAURENCIN CATO T | Director |
Dec 09 '24 |
Sale |
31.85 |
2,691 |
85,708 |
23,013 |
1.61%
1.65%
大文字化:
|
ボリューム (24 時間):